Skip to main content
SpringerLink
Log in

Epidemiology of Age-Related Macular Degeneration Early in the 21st Century

  • Chapter
Retinal Degenerations

Part of the book series: Ophthalmology Research ((OPHRES))

Abstract

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness and moderate visual impairment in older, white persons (1–11) and will remain a major threat to vision in coming decades (12,13). AMD research has progressed substantially in the last quarter of the 20th century and provides clues for future research directions (12,14–27). Although the exact etiology of AMD remains uncertain (12), we now have a considerably better understanding of this condition than 30 yr ago. The purpose of this chapter is to summarize progress on understanding the epidemiology of AMD in the last two to three decades.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ferris FL 3rd, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640–1642.

    PubMed  Google Scholar 

  2. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore [see comments]. N Engl J Med 1991;325:1412–1417.

    Article  PubMed  CAS  Google Scholar 

  3. Rosenberg T, Klie F. The incidence of registered blindness caused by age-related macular degeneration. Acta Ophthalmol Scand 1996;74:399–402.

    PubMed  CAS  Google Scholar 

  4. Evans J, Wormald R. Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol 1996;80:9–14.

    Article  PubMed  CAS  Google Scholar 

  5. Rahmani B, Tielsch JM, Katz J, et al. The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology 1996;103:1721–1726.

    PubMed  CAS  Google Scholar 

  6. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182–191.

    PubMed  CAS  Google Scholar 

  7. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:357–364.

    PubMed  CAS  Google Scholar 

  8. Wang JJ, Foran S, Mitchell P. Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 2000;28:268–273.

    Article  PubMed  CAS  Google Scholar 

  9. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998;116:653–658.

    PubMed  CAS  Google Scholar 

  10. Rodriguez J, Sanchez R, Munoz B, et al. Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology 2002;109:737–743.

    Article  PubMed  Google Scholar 

  11. Evans JR, Fletcher AE, Wormald RP. Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Ophthalmology 2004;111:513–517.

    Article  PubMed  Google Scholar 

  12. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003;48:257–293.

    Article  PubMed  Google Scholar 

  13. Fine SL. Age-related macular degeneration 1969–2004: a 35-year personal perspective. Am J Ophthalmol 2005;139:405–420.

    Article  PubMed  Google Scholar 

  14. Hyman L. Epidemiology of eye disease in the elderly. Eye 1987;1:330–341.

    PubMed  Google Scholar 

  15. Vingerling JR, Klaver CC, Hofman A, de Jong PT. Epidemiology of age-related maculopathy. Epidemiol Rev 1995;17:347–360.

    PubMed  CAS  Google Scholar 

  16. Hawkins BS, Bird A, Klein R, West SK. Epidemiology of age-related macular degeneration. Mol Vis 1999;5:26.

    PubMed  CAS  Google Scholar 

  17. Klein R, Klein BE, Cruickshanks KJ. The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 1999;18:371–389.

    Article  PubMed  CAS  Google Scholar 

  18. Klein R. Epidemiology. In: Berger JW, Fine SL, and Maguire MG, eds. Age-related Macular Degeneration. St. Louis: Mosby, 1999:31–56.

    Google Scholar 

  19. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001;20:227–253.

    Article  PubMed  CAS  Google Scholar 

  20. Gottlieb JL. Age-related macular degeneration. JAMA 2002;288:2233–2236.

    Article  PubMed  Google Scholar 

  21. Hyman L, Neborsky R. Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol 2002;13:171–175.

    Article  PubMed  Google Scholar 

  22. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. Epidemiology of agerelated maculopathy: a review. Eur J Epidemiol 2003;18:845–854.

    Article  PubMed  Google Scholar 

  23. Klein R, Peto T, Bird A, VanNewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004;137:486–495.

    Article  PubMed  Google Scholar 

  24. Tuo J, Bojanowski CM, Chan CC. Genetic factors of age-related macular degeneration. Prog Retin Eye Res 2004;23:229–249.

    Article  PubMed  CAS  Google Scholar 

  25. Seddon JM, Chen CA. The epidemiology of age-related macular degeneration. Int Ophthalmol Clin 2004;44:17–39.

    Article  PubMed  Google Scholar 

  26. Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. N Engl J Med 2002;342:483–492.

    Article  Google Scholar 

  27. Klein R. Epidemiology of Age-related macular degeneration. In: Penfold PL and Provis JM, eds. Macular Degeneration. Springer-Verlag GmbH Co, Berlin 2004:79–102.

    Google Scholar 

  28. Klein R, Davis M, Magli Y, Segal P, Klein B, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98:1128–1134.

    PubMed  CAS  Google Scholar 

  29. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367–374.

    CAS  Google Scholar 

  30. Friedman DS, Katz J, Bressler NM, Rahmani B, Tielsch JM. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology 1999;106:1049–1055.

    Article  PubMed  CAS  Google Scholar 

  31. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933–943.

    PubMed  CAS  Google Scholar 

  32. Schachat AP, Hyman L, Leske MC, Connell AM, Wu SY. Features of age-related macular degeneration in a black population. The Barbados Eye Study Group. Arch Ophthalmol 1995;113:728–735.

    PubMed  CAS  Google Scholar 

  33. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995;102:205–210.

    PubMed  CAS  Google Scholar 

  34. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102:1450–1460.

    PubMed  CAS  Google Scholar 

  35. Klein R, Clegg L, Cooper LS, et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 1999;117:1203–1210.

    PubMed  CAS  Google Scholar 

  36. VanNewkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR, McCarty CA. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 2000;107:1593–1600.

    Article  PubMed  CAS  Google Scholar 

  37. Oshima Y, Ishibashi T, Murata T, Tahara Y, Kiyohara Y, Kubota T. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol 2001;85:1153–1157.

    Article  PubMed  CAS  Google Scholar 

  38. Klein R, Klein BE, Marino EK, et al. Early age-related maculopathy in the cardiovascular health study. Ophthalmology 2003;110:25–33.

    Article  PubMed  Google Scholar 

  39. Jonasson F, Arnarsson A, Sasaki H, Peto T, Sasaki K, Bird AC. The prevalence of age-related maculopathy in iceland: Reykjavik eye study. Arch Ophthalmol 2003;121: 379–385.

    PubMed  Google Scholar 

  40. Varma R, Fraser-Bell S, Tan S, Klein R, Azen SP. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. Ophthalmology 2004;111: 1288–1297.

    Article  PubMed  Google Scholar 

  41. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001;108:697–704.

    Article  PubMed  CAS  Google Scholar 

  42. Tomany SC, Wang JJ, van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004;111:1280–1287.

    Article  PubMed  Google Scholar 

  43. van Leeuwen R, Tomany SC, Wang JJ, et al. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmology 2004;111:1169–1175.

    Article  PubMed  Google Scholar 

  44. Friedman DS, O’Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564–572.

    Article  PubMed  Google Scholar 

  45. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 2002; 109:1767–1779.

    Article  PubMed  Google Scholar 

  46. Schick JH, Iyengar SK, Klein BE, et al. A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. Am J Hum Genet 2003;72:1412–1424.

    Article  PubMed  CAS  Google Scholar 

  47. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001;132:668–681.

    Article  Google Scholar 

  48. Age-Related Eye Disease Study Research Group. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss. AREDS Report Number 8. Arch Ophthalmol 2001;119:1417–1436.

    Google Scholar 

  49. Klaver CC, Assink JJ, van Leeuwen R, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 2001;42:2237–2241.

    PubMed  CAS  Google Scholar 

  50. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 2003;121:519–526.

    Article  PubMed  Google Scholar 

  51. van Leeuwen R, Chakravarthy U, Vingerling JR, et al. Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm film? Ophthalmology 2003;110:1540–1544.

    Article  PubMed  Google Scholar 

  52. Scholl HP, Dandekar SS, Peto T, et al. What is lost by digitizing stereoscopic fundus color slides for macular grading in age-related maculopathy and degeneration? Ophthalmology 2004;111:125–132.

    Article  PubMed  Google Scholar 

  53. Sperduto RD, Seigel D. Senile lens and senile macular changes in a population-based sample. Am J Ophthalmol 1980;90:86–91.

    PubMed  CAS  Google Scholar 

  54. Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 1989;107:847–852.

    PubMed  CAS  Google Scholar 

  55. Mitchell RA. Prevalence of age related macular degeneration in persons aged 50 years and over resident in Australia. J Epidemiol Community Health 1993;47:42–45.

    Article  PubMed  CAS  Google Scholar 

  56. Wu L. Study of aging macular degeneration in China. Jpn J Ophthalmol 1987;31:349–367.

    PubMed  CAS  Google Scholar 

  57. Vinding T. Age-related macular degeneration. Macular changes, prevalence and sex ratio. An epidemiological study of 1000 aged individuals. Acta Ophthalmol Copenh 1989;67:609–616.

    PubMed  CAS  Google Scholar 

  58. West SK, Munoz B, Rubin GS, et al. Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation. Invest. Ophthalmol Vis Sci 1997;38:72–82.

    PubMed  CAS  Google Scholar 

  59. Freeman EE, Munoz B, West SK, Tielsch JM, Schein OD. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol 2003;135:849–856.

    Article  PubMed  Google Scholar 

  60. Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the blue mountains eye study. Ophthalmology 2002;109:1092–1097.

    Article  PubMed  Google Scholar 

  61. Klein R, Rowland ML, Harris MI. Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. Ophthalmology 1995; 102:371–381.

    PubMed  CAS  Google Scholar 

  62. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology 1999;106:1056–1065.

    Article  PubMed  CAS  Google Scholar 

  63. Lavin MJ, Eldem B, Gregor ZJ. Symmetry of disciform scars in bilateral age-related macular degeneration. Br J Ophthalmol 1991;75:133–136.

    Article  PubMed  CAS  Google Scholar 

  64. Wang JJ, Mitchell P, Smith W, Cumming RG. Bilateral involvement by age related maculopathy lesions in a population. Br J Ophthalmol 1998;82:743–747.

    PubMed  CAS  Google Scholar 

  65. Cruickshanks KJ, Hamman RF, Klein R, Nondahl DM, Shetterly SM. The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. Arch Ophthalmol 1997;115:242–250.

    PubMed  CAS  Google Scholar 

  66. Frank RN, Puklin JE, Stock C, Canter LA. Race, iris color, and age-related macular degeneration. Trans. Am Ophthalmol Soc 2000;98:109–115.

    CAS  Google Scholar 

  67. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104:7–21.

    PubMed  CAS  Google Scholar 

  68. Bressler NM, Munoz B, Maguire MG, et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol 1995;113:301–308.

    PubMed  CAS  Google Scholar 

  69. Podgor MJ, Leske MC, Ederer F. Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy. Am J Epidemiol 1983;118:206–212.

    PubMed  CAS  Google Scholar 

  70. Klaver CC, Assink JJ, van Leeuwen R, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 2001;42:2237–2241.

    PubMed  CAS  Google Scholar 

  71. Mukesh BN, Dimitrov PN, Leikin S, et al. Five-year incidence of age-related maculopathy: the Visual Impairment Project. Ophthalmology 2004;111:1176–1182.

    Article  PubMed  Google Scholar 

  72. Jonasson F, Arnarsson A, Peto T, Sasaki H, Sasaki K, Bird AC. Five-year incidence of age-related maculopathy in the Reykjavik Eye Study. Ophthalmology 2005;112:132–138.

    Article  PubMed  Google Scholar 

  73. Javitt JC, Zhou Z, Maguire MG, Fine SL, Willke RJ. Incidence of exudative age-related macular degeneration among elderly Americans. Ophthalmology 2003;110:1534–1539.

    Article  PubMed  Google Scholar 

  74. Jaakkola A, Anttila PM, Immonen I. Interferon alpha-2a in the treatment of exudative senile macular degeneration. Acta Ophthalmol Copenh 1994;72:545–549.

    Article  PubMed  CAS  Google Scholar 

  75. Gregor Z, Bird AC, Chisholm IH. Senile disciform macular degeneration in the second eye. Br J Ophthalmol 1997;61:141–147.

    Article  Google Scholar 

  76. Strahlman ER, Fine SL, Hillis A. The second eye of patients with senile macular degeneration. Arch Ophthalmol 1983;101:1191–1193.

    PubMed  CAS  Google Scholar 

  77. Roy M, Kaiser-Kupfer M. Second eye involvement in age-related macular degeneration: a four-year prospective study. Eye 1990;4:813–818.

    PubMed  Google Scholar 

  78. Macular Photocoagulation Study Group. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group. Arch Ophthalmol 1993;111:1189–1199.

    Google Scholar 

  79. Chang B, Yannuzzi LA, Ladas ID, Guyer DR, Slakter JS, Sorenson JA. Choroidal neovascularization in second eyes of patients with unilateral exudative age-related macular degeneration. Ophthalmology 1995;102:1380–1386.

    PubMed  CAS  Google Scholar 

  80. Sandberg MA, Weiner A, Miller S, Gaudio AR. High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmology 1998;105:441–447.

    Article  PubMed  CAS  Google Scholar 

  81. Pieramici DJ, Bressler SB. Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye. Curr Opin Ophthalmol 1998;9:38–46.

    Article  PubMed  CAS  Google Scholar 

  82. Uyama M, Takahashi K, Ida N, et al. The second eye of Japanese patients with unilateral exudative age related macular degeneration. Br J Ophthalmol 2000;84:1018–1023.

    Article  PubMed  CAS  Google Scholar 

  83. Smiddy WE, Fine SL. Prognosis of patients with bilateral macular drusen. Ophthalmology 1984;91:271–277.

    PubMed  CAS  Google Scholar 

  84. Bressler NM, Bressler SB, Seddon JM, Gragoudas ES, Jacobson LP. Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. Retina 1988;8:109–114.

    Article  PubMed  CAS  Google Scholar 

  85. Holz FG, Wolfensberger TJ, Piguet B, et al. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 1994;101:1522–1528.

    PubMed  CAS  Google Scholar 

  86. Arnold JJ, Sarks SH, Killingsworth MC, Sarks JP. Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 1995;15:183–191.

    Article  PubMed  CAS  Google Scholar 

  87. Wang Q, Chappell RJ, Klein R, et al. Pattern of age-related maculopathy in the macular area. The Beaver Dam Eye Study. Invest. Ophthalmol Vis Sci 1996;37:2234–2242.

    PubMed  CAS  Google Scholar 

  88. Wang JJ, Foran S, Smith W, Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol 2003;121:658–663.

    Article  PubMed  Google Scholar 

  89. Knudtson MD, Klein R, Klein BE, Lee KE, Meuer SM, Tomany SC. Location of lesions associated with age-related maculopathy over a 10-year period: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 2004;45:2135–2142.

    Article  PubMed  Google Scholar 

  90. Leske MC, Wu SY, Hyman L, Hennis A, Nemesure B, Schachat AP. Four-year incidence of macular changes in the Barbados Eye Studies. Ophthalmology 2004;111:706–711.

    Article  PubMed  Google Scholar 

  91. Hyman LG, Lilienfeld AM, Ferris FL 3rd, Fine SL. Senile macular degeneration: a casecontrol study. Am J Epidemiol 1983;118:213–227.

    PubMed  CAS  Google Scholar 

  92. Smith W, Mitchell P. Family history and age-related maculopathy: the Blue Mountains Eye Study. Aust NZ J Ophthalmol 1998;26:203–206.

    CAS  Google Scholar 

  93. Klaver CC, Wolfs RC, Assink JJ, van Duijn CM, Hofman A, de Jong PT. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 1998;116:1646–1651.

    PubMed  CAS  Google Scholar 

  94. Klein BE, Klein R, Lee KE, Moore EL, Danforth L. Risk of incident age-related eye diseases in people with an affected sibling: The Beaver Dam Eye Study. Am J Epidemiol 2001;154:207–211.

    Article  PubMed  CAS  Google Scholar 

  95. Fraser-Bell S, Donofrio J, Wu J, Klein R, Azen SP, Varma R. Sociodemographic factors and age-related macular degeneration in Latinos: The Los Angeles Latino Eye Study. Am J Ophthalmol 2005;139:30–38.

    Article  PubMed  Google Scholar 

  96. Heiba IM, Elston RC, Klein BE, Klein R. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol 1994;11:51–67.

    Article  PubMed  CAS  Google Scholar 

  97. Silvestri G, Johnston PB, Hughes AE. Is genetic predisposition an important risk factor in age-related macular degeneration? Eye 1994;8:564–568.

    PubMed  Google Scholar 

  98. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol 1997;123:199–206.

    PubMed  CAS  Google Scholar 

  99. Keverline MR, Mah TS, Keverline PO, Gorin MB. A practice-based survey of familial age-related maculopathy. Ophthalmic Genet 1998;19:19–26.

    Article  PubMed  CAS  Google Scholar 

  100. Yoshida A, Yoshida M, Yoshida S, Shiose S, Hiroish G, Ishibashi T. Familial cases with age-related macular degeneration. Jpn J Ophthalmol 2000;44:290–295.

    Article  PubMed  CAS  Google Scholar 

  101. Klein ML, Mauldin WM, Stoumbos VD. Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol 1994;112:932–937.

    PubMed  CAS  Google Scholar 

  102. Gottfredsdottir MS, Sverrisson T, Musch DC, Stefansson E. Age related macular degeneration in monozygotic twins and their spouses in Iceland. Acta Ophthalmol Scand 1999; 77:422–425.

    Article  PubMed  CAS  Google Scholar 

  103. Hammond CJ, Webster AR, Snieder H, Bird AC, Gilbert CE, Spector TD. Genetic influence on early age-related maculopathy: a twin study. Ophthalmology 2002;109:730–736.

    Article  PubMed  Google Scholar 

  104. Grizzard SW, Arnett D, Haag SL. Twin study of age-related macular degeneration. Ophthalmic Epidemiol 2003;10:315–322.

    Article  PubMed  Google Scholar 

  105. de Jong PT, Bergen AA, Klaver CC, van Duijn CM, Assink JM. Age-related maculopathy: its genetic basis. Eye 2001;15:396–400.

    PubMed  Google Scholar 

  106. Yates JR, Moore AT. Genetic susceptibility to age related macular degeneration. J Med Genet 2000;37:83–87.

    Article  PubMed  CAS  Google Scholar 

  107. Klein ML, Schultz DW, Edwards A, et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol 1998;116: 1082–1088.

    PubMed  CAS  Google Scholar 

  108. Weeks DE, Conley YP, Tsai HJ, et al. Age-related maculopathy: an expanded genomewide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Am J Ophthalmol 2001;132:682–692.

    Article  PubMed  CAS  Google Scholar 

  109. Kniazeva M, Traboulsi EI, Yu Z, et al. A new locus for dominant drusen and macular degeneration maps to chromosome 6q14. Am J Ophthalmol 2000;130:197–202.

    Article  PubMed  CAS  Google Scholar 

  110. Hayashi M, Merriam JE, Klaver CC, et al. Evaluation of the ARMD1 locus on 1q25-31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1. Ophthalmic Genet 2004;25:111–119.

    Article  PubMed  CAS  Google Scholar 

  111. Allikmets R, Shroyer NF, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997;277:1805–1807.

    Article  PubMed  CAS  Google Scholar 

  112. Zhang K, Kniazeva M, Hutchinson A, Han M, Dean M, Allikmets R. The ABCR gene in recessive and dominant Stargardt diseases: a genetic pathway in macular degeneration. Genomics 1999;60:234–237.

    Article  PubMed  CAS  Google Scholar 

  113. Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 2000;67:487–491.

    Article  PubMed  CAS  Google Scholar 

  114. Shroyer NF, Lewis RA, Yatsenko AN, Wensel TG, Lupski JR. Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration. Hum Mol Genet 2001;10: 2671–2678.

    Article  PubMed  CAS  Google Scholar 

  115. De La Paz MA, Guy VK, Abou-Donia S, et al. Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration. Ophthalmology 1999;106:1531–1536.

    Article  Google Scholar 

  116. Fuse N, Suzuki T, Wada Y, et al. Molecular genetic analysis of ABCR gene in Japanese dry form age-related macular degeneration. Jpn. J Ophthalmol 2000;44:245–249.

    Article  PubMed  CAS  Google Scholar 

  117. Souied EH, Ducroq D, Rozet JM, et al. ABCR gene analysis in familial exudative agerelated macular degeneration. Invest Ophthalmol Vis Sci 2000;41:244–247.

    PubMed  CAS  Google Scholar 

  118. Guymer RH, Heon E, Lotery AJ, et al. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 2001;119:745–751.

    PubMed  CAS  Google Scholar 

  119. Webster AR, Heon E, Lotery AJ, et al. An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci 2001;42:1179–1189.

    PubMed  CAS  Google Scholar 

  120. Schmidt S, Postel EA, Agarwal A, et al. Detailed analysis of allelic variation in the ABCA4 gene in age-related maculopathy. Invest Ophthalmol Vis Sci 2003;44:2868–2875.

    Article  PubMed  Google Scholar 

  121. Souied EH, Benlian P, Amouyel P, et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998;125:353–359.

    Article  PubMed  CAS  Google Scholar 

  122. Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998;63:200–206.

    Article  PubMed  CAS  Google Scholar 

  123. Pang CP, Baum L, Chan WM, Lau TC, Poon PM, Lam DS. The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica 2000;214:289–291.

    Article  PubMed  CAS  Google Scholar 

  124. Schmidt S, Saunders AM, De La Paz MA, et al. Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. Mol Vis 2000;6:287–293.

    PubMed  CAS  Google Scholar 

  125. Simonelli F, Margaglione M, Testa F, et al. Apolipoprotein E polymorphisms in agerelated macular degeneration in an Italian population. Ophthalmic Res 2001;33:325–328.

    Article  PubMed  CAS  Google Scholar 

  126. Schmidt S, Klaver C, Saunders A, et al. A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet 2002;23:209–223.

    Article  PubMed  Google Scholar 

  127. Schultz DW, Klein ML, Humpert A, et al. Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch Ophthalmol 2003;121:679–683.

    Article  PubMed  CAS  Google Scholar 

  128. Zareparsi S, Reddick AC, Branham KE, et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci 2004;45:1306–1310.

    Article  PubMed  Google Scholar 

  129. Baird PN, Guida E, Chu DT, Vu HT, Guymer RH. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2004;45:1311–1315.

    Article  PubMed  Google Scholar 

  130. Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 2000;130:769–773.

    Article  PubMed  CAS  Google Scholar 

  131. Ikeda T, Obayashi H, Hasegawa G, et al. Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol 2001;132:191–195.

    Article  PubMed  CAS  Google Scholar 

  132. Guymer RH, McNeil R, Cain M, et al. Analysis of the Arg345Trp disease-associated allele of the EFEMP1 gene in individuals with early onset drusen or familial age-related macular degeneration. Clin. Experiment. Ophthalmol 2002;30:419–423.

    Article  PubMed  Google Scholar 

  133. Baird PN, Chu D, Guida E, Vu HT, Guymer R. Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degeneration. Am J Ophthalmol 2004;138:665–666.

    Article  PubMed  CAS  Google Scholar 

  134. Sauer CG, White K, Stohr H, et al. Evaluation of the G protein coupled receptor-75 (GPR75) in age related macular degeneration. Br J Ophthalmol 2001;85:969–975.

    Article  PubMed  CAS  Google Scholar 

  135. Zurdel J, Finckh U, Menzer G, Nitsch RM, Richard G. CST3 genotype associated with exudative age related macular degeneration. Br J Ophthalmol 2002;86:214–219.

    Article  PubMed  Google Scholar 

  136. Stone EM, Braun TA, Russell SR, et al. Missense variations in the fibulin 5 gene and agerelated macular degeneration. N Engl J Med 2004;351:346–353.

    Article  PubMed  CAS  Google Scholar 

  137. Kenealy SJ, Schmidt S, Agarwal et al. Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26. Mol Vis 2004;10:57–61.

    PubMed  CAS  Google Scholar 

  138. Iyengar SK, Song D, Klein BE, et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet 2004;74:20–39.

    Article  PubMed  CAS  Google Scholar 

  139. Majewski J, Schultz DW, Weleber RG, et al. Age-related macular degeneration-a genome scan in extended families. Am J Hum Genet 2003;73:540–550.

    Article  PubMed  CAS  Google Scholar 

  140. Klein RJ, Zeiss C, Chew EY, et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration. Science 2005;308:362–364.

    Article  CAS  Google Scholar 

  141. Edwards AO, Ritter IR, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement Factor H Polymorphism and Age-Related Macular Degeneration. Science 2005;308:421–424.

    Article  PubMed  CAS  Google Scholar 

  142. Haines JL, Hauser MA, Schmidt S, et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration. Science 2005;308:419–421.

    Article  PubMed  CAS  Google Scholar 

  143. Gorin MB, Breitner JC, de Jong PT, et al. The genetics of age-related macular degeneration. Mol Vis 1999;5:29.

    PubMed  CAS  Google Scholar 

  144. Allikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997; 15:236–246.

    Article  PubMed  CAS  Google Scholar 

  145. Stone EM, Webster AR, Vandenburgh K, et al. Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration [letter]. Nat Genet 1998; 20:328–329.

    Article  PubMed  CAS  Google Scholar 

  146. Rivera A, White K, Stohr H, et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet 2000;67:800–813.

    Article  PubMed  CAS  Google Scholar 

  147. Daiger SP. Was the Human Genome Project Worth the Effort? Science 2005;308:362–364.

    Article  PubMed  CAS  Google Scholar 

  148. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701–1708.

    Google Scholar 

  149. Vinding T, Appleyard M, Nyboe J, Jensen G. Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol Copenh 1992;70:66–72.

    PubMed  CAS  Google Scholar 

  150. Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 1993:137:190–200.

    PubMed  CAS  Google Scholar 

  151. Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol 1996:114:1193–1196.

    PubMed  CAS  Google Scholar 

  152. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 1996;114:1518–1523.

    PubMed  CAS  Google Scholar 

  153. McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor HR. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 2001;119: 1455–1462.

    PubMed  CAS  Google Scholar 

  154. Delcourt C, Diaz JL, Ponton Sanchez A, Papoz L. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees al’Age. Arch Ophthalmol 1998;116:1031–1035.

    PubMed  CAS  Google Scholar 

  155. Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 1996;276: 1147–1151.

    Article  PubMed  CAS  Google Scholar 

  156. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996;276:1141–1146.

    Article  PubMed  CAS  Google Scholar 

  157. Tamakoshi A, Yuzawa M, Matsui M, Uyama M, Fujiwara NK, Ohno Y. (1997). Smoking and neovascular form of age related macular degeneration in late middle aged males: findings from a case-control study in Japan. Research Committee on Chorioretinal Degenerations. Br J Ophthalmol 1997;81:901–904.

    PubMed  CAS  Google Scholar 

  158. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: agerelated eye disease study report number 3. Ophthalmology 2000;107:2224–2232.

    Article  Google Scholar 

  159. DeAngelis MM, Lane AM, Shah CP, Ott J, Dryja TP, Miller JW. Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 2004;122:575–580.

    Article  PubMed  Google Scholar 

  160. Klaver CC, Assink JJ, Vingerling JR, Hofman A, de Jong PT. Smoking is also associated with age-related macular degeneration in persons aged 85 years and older: The Rotterdam Study [letter]. Arch Ophthalmol 1997;115:945.

    PubMed  CAS  Google Scholar 

  161. Mitchell P, Wang JJ, Smith W, Leeder SR. Smoking and the 5-year incidence of agerelated maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 2002;120: 1357–1363.

    PubMed  Google Scholar 

  162. Klein R, Klein BE, Moss SE. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am J Epidemiol 1998;147:103–110.

    PubMed  CAS  Google Scholar 

  163. Klein R, Klein BE, Tomany SC, Moss SE. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol 2002;156: 589–598.

    Article  PubMed  Google Scholar 

  164. Kelly SP, Edwards R, Elton P, Mitchell P. Age related macular degeneration: smoking entails major risk of blindness. BMJ 2003;326:1458–1459.

    Article  PubMed  Google Scholar 

  165. Suner IJ, Espinosa-Heidmann DG, Marin-Castano ME, Hernandez EP, Pereira-Simon S, Cousins SW. Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2004;45:311–317.

    Article  PubMed  Google Scholar 

  166. Chan D. Cigarette smoking and age-related macular degeneration. Optom. Vis Sci 1998;75:476–484.

    Article  PubMed  CAS  Google Scholar 

  167. DeBlack SS. Cigarette smoking as a risk factor for cataract and age-related macular degeneration: a review of the literature. Optometry 2003;74:99–110.

    PubMed  Google Scholar 

  168. Mitchell P, Chapman S, Smith W. “Smoking is a major cause of blindness”: a new cigarette pack warning? Med J Aust 1999;171:173–174.

    PubMed  CAS  Google Scholar 

  169. Schwartz D. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Surv Ophthalmol 1994;39:84–85.

    Article  PubMed  CAS  Google Scholar 

  170. Obisesan TO, Hirsch R, Kosoko O, Carlson L, Parrott M. Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1. J Am Geriatr Soc 1998;46:1–7.

    PubMed  CAS  Google Scholar 

  171. Ritter LL, Klein R, Klein BE, Mares Perlman JA, Jensen SC. Alcohol use and age-related maculopathy in the Beaver Dam Eye Study. Am J Ophthalmol 1995;120:190–196.

    PubMed  CAS  Google Scholar 

  172. Smith W. Mitchell P. Alcohol intake and age-related maculopathy. Am J Ophthalmol 1996;122:743–745.

    PubMed  CAS  Google Scholar 

  173. Moss SE, Klein R, Klein BE, Jensen SC, Meuer SM. Alcohol consumption and the 5-year incidence of age-related maculopathy: the Beaver Dam eye study. Ophthalmology 1998;105:789–794.

    Article  PubMed  CAS  Google Scholar 

  174. Ajani UA, Christen WG, Manson JE, et al. A prospective study of alcohol consumption and the risk of age-related macular degeneration. Ann Epidemiol 1999;9:172–177.

    Article  PubMed  CAS  Google Scholar 

  175. Cho E, Hankinson SE, Willett WC, et al. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol 2000;118:681–688.

    PubMed  CAS  Google Scholar 

  176. Sarma U, Brunner E, Evans J, Wormald R. Nutrition and the epidemiology of cataract and age-related maculopathy. Eur J Clin Nutr 1994;48:1–8.

    PubMed  CAS  Google Scholar 

  177. Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vis 1999;5:32.

    PubMed  CAS  Google Scholar 

  178. Gu X, Meer SG, Miyagi M, et al. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 2003;278:42,027–42,035.

    Article  PubMed  CAS  Google Scholar 

  179. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group [see comments]. J Am Med Assoc 1994;272:1413–1420.

    Article  CAS  Google Scholar 

  180. Pratt S. Dietary prevention of age-related macular degeneration. J Am Optom Assoc 1999;70:39–47.

    PubMed  CAS  Google Scholar 

  181. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 2001;42:439–446.

    PubMed  CAS  Google Scholar 

  182. Horowitz S. Lutein update: protecting the eyes and the heart with the yellow carotenoid. Alt Comp Ther 2000;6:272–277.

    Google Scholar 

  183. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993;111:104–109.

    Google Scholar 

  184. Snellen EL, Verbeek AL, Van Den Hoogen GW, Cruysberg JR, Hoyng CB. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand 2002;80:368–371.

    Article  PubMed  CAS  Google Scholar 

  185. Gale CR, Hall NF, Phillips DI, Martyn CN. Lutein and zeaxanthin status and risk of agerelated macular degeneration. Invest Ophthalmol Vis Sci 2003;44:2461–2465.

    Article  PubMed  Google Scholar 

  186. De La Paz MA, Zhang J, Fridovich I. Red blood cell antioxidant enzymes in age-related macular degeneration. Br J Ophthalmol 1996;80:445–450.

    Article  Google Scholar 

  187. Goldberg J, Flowerdew G, Smith E, Brody J, Tso M. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Survey. Am J Epidemiol 1988;128:700–710.

    PubMed  CAS  Google Scholar 

  188. Vaicaitiene R, Luksiene DK, Paunksnis A, Cerniauskiene LR, Domarkiene S, Cimbalas A. Age-related maculopathy and consumption of fresh vegetables and fruits in urban elderly. Medicina (Kaunas) 2003;39:1231–1236.

    Google Scholar 

  189. Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol 2004;122:883–892.

    Article  PubMed  Google Scholar 

  190. Seddon JM, Hennekens CH. Vitamins, minerals, and macular degeneration. Promising but unproven hypotheses [editorial]. Arch Ophthalmol 1994;112:176–179.

    PubMed  CAS  Google Scholar 

  191. Cooper DA, Eldridge AL, Peters JC. Dietary carotenoids and certain cancers, heart disease, and age-related macular degeneration: a review of recent research. Nutr Rev 1999;57:201–214.

    Article  PubMed  CAS  Google Scholar 

  192. West S, Vitale S, Hallfrisc J, et al. Are antioxidants or supplements protective for agerelated macular degeneration? Arch Ophthalmol 1994;112:222–227.

    PubMed  CAS  Google Scholar 

  193. Mares-Perlman JA, Brady WE, Klein R, et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol 1995;113:1518–1523.

    PubMed  CAS  Google Scholar 

  194. Smith W, Mitchell P, Rochester C. Serum beta carotene, alpha tocopherol, and age-related maculopathy: the Blue Mountains Eye Study. Am J Ophthalmol 1997;124:838–840.

    PubMed  CAS  Google Scholar 

  195. Mares-Perlman JA, Fisher AI, Klein R, et al. Lutein and Zeaxanthin in the Diet and Serum and Their Relation to Age-Related Maculopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2001;153:424–432.

    Article  PubMed  CAS  Google Scholar 

  196. Mares-Perlman JA, Klein R, Klein BE, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 1996;114:991–997.

    PubMed  CAS  Google Scholar 

  197. Smith W, Mitchell P, Webb K, Leeder SR. Dietary antioxidants and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 1999;106:761–767.

    Article  PubMed  CAS  Google Scholar 

  198. Kuzniarz M, Mitchell P, Flood VM, Wang JJ. Use of vitamin and zinc supplements and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2002;9:283–295.

    Article  PubMed  Google Scholar 

  199. Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees al’ Age. Arch Ophthalmol 1999;117:1384–1390.

    CAS  Google Scholar 

  200. Delcourt C, Cristol JP, Leger CL, Descomps B, Papoz L. Associations of antioxidant enzymes with cataract and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees al’ Age. Ophthalmology 1999;106:215–222.

    CAS  Google Scholar 

  201. VandenLangenberg GM, Mares Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early agerelated maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 1998;148:204–214.

    PubMed  CAS  Google Scholar 

  202. Christen WG, Ajani UA, Glynn RJ, et al. Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am J Epidemiol 1999;149:476–484.

    PubMed  CAS  Google Scholar 

  203. Cho E, Stampfer MJ, Seddon JM, et al. Prospective study of zinc intake and the risk of age-related macular degeneration. Ann Epidemiol 2001;11:328–336.

    Article  PubMed  CAS  Google Scholar 

  204. Flood V, Smith W, Wang JJ, Manzi F, Webb K, Mitchell P. Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 2002;109:2272–2278.

    Article  PubMed  Google Scholar 

  205. Evans JR. Antioxidant vitamin and mineral supplements for age-related macular degeneration. Cochrane Database Syst Rev 2002;volume 2.

    Google Scholar 

  206. Richer S. Multicenter ophthalmic and nutritional age-related macular degeneration study-part 2: antioxidant intervention and conclusions. J Am Optom Assoc 1996;67:30–49.

    PubMed  CAS  Google Scholar 

  207. Stur M, Tittl M, Reitner A, Meisinger V. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996;37:1225–1235.

    PubMed  CAS  Google Scholar 

  208. Teikari JM, Laatikainen L, Virtamo J, et al. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand 1998; 76:224–229.

    Article  PubMed  CAS  Google Scholar 

  209. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004;75:216–230.

    PubMed  Google Scholar 

  210. Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res 2004;79:21–27.

    Article  PubMed  CAS  Google Scholar 

  211. Seigel D. AREDS investigators distort findings. Arch Ophthalmol 2002;120:100–101.

    PubMed  Google Scholar 

  212. Ambati J, Ambati BK. Age-related eye disease study caveats. Arch Ophthalmol 2002;120:997–999.

    PubMed  Google Scholar 

  213. Tomany SC, Klein R, Klein BE. The relation of coffee and caffeine to the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Am J Ophthalmol 2001;132:271–273.

    Article  PubMed  CAS  Google Scholar 

  214. Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol 2003;121:1728–1737.

    Article  PubMed  Google Scholar 

  215. Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M. Dietary fat and age-related maculopathy. Arch Ophthalmol 1995;113:743–748.

    PubMed  CAS  Google Scholar 

  216. Friedman E. Dietary fat and age-related maculopathy [letter]. Arch Ophthalmol 1996;114:235–236.

    PubMed  CAS  Google Scholar 

  217. Cho E, Hung S, Willett WC, Spiegelman D, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001;73:209–218.

    PubMed  CAS  Google Scholar 

  218. Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol 1999;6:125–143.

    Article  PubMed  CAS  Google Scholar 

  219. Espinosa-Heidmann DG, Sall J, Hernandez EP, Cousins SW. Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E. Invest Ophthalmol Vis Sci 2004;45:260–266.

    Article  PubMed  Google Scholar 

  220. Sarks JP, Sarks SH, Killingsworth MC. Evolution of soft drusen in age-related macular degeneration. Eye 1994;8:269–283.

    PubMed  Google Scholar 

  221. Sanders TA, Haines AP, Wormald R, Wright LA, Obeid O. Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr 1993;57:428–433.

    PubMed  CAS  Google Scholar 

  222. Smith W, Mitchell P, Leeder SR. Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol 2000;118:401–404.

    PubMed  CAS  Google Scholar 

  223. Heuberger RA, Mares-Perlman JA, Klein R, Klein BE, Millen AE, Palta M. Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Arch Ophthalmol 2001;119:1833–1838.

    PubMed  CAS  Google Scholar 

  224. Seddon JM, Rosner B, Sperduto RD, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001;119:1191–1199.

    PubMed  CAS  Google Scholar 

  225. McGwin G Jr., Owsley C, Curcio CA, Crain RJ. The association between statin use and age related maculopathy. Br J Ophthalmol 2003;87:1121–1125.

    Article  PubMed  Google Scholar 

  226. Wilson HL, Schwartz DM, Bhatt HR, McCulloch CE, Duncan JL. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol 2004;137:615–624.

    Article  PubMed  CAS  Google Scholar 

  227. McCarty CA, Mukesh BN, Guymer RH, Baird PN, Taylor HR. Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med J Aust 2001; 175:340.

    PubMed  CAS  Google Scholar 

  228. Klein R, Klein BE, Tomany SC, Danforth LG, Cruickshanks KJ. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol 2003;121:1151–1155.

    Article  PubMed  CAS  Google Scholar 

  229. Klein R, Klein BE, Jensen SC, et al. Medication use and the five-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2001; 119:1354–1359.

    PubMed  CAS  Google Scholar 

  230. van Leeuwen R, Vingerling JR, Hofman A, de Jong PT, Stricker BH. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement. BMJ 2003;326:255–256.

    Article  PubMed  Google Scholar 

  231. Holz FG, Piguet B, Minassian DC, Bird AC, Weale RA. Decreasing stromal iris pigmentation as a risk factor for age-related macular degeneration. Am J Ophthalmol 1994;117:19–23.

    PubMed  CAS  Google Scholar 

  232. Chaine G, Hullo A, Sahel J, et al. Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group. Br J Ophthalmol 1998;82:996–1002.

    PubMed  CAS  Google Scholar 

  233. Sandberg MA, Gaudio AR, Miller S, Weiner A. Iris pigmentation and extent of disease in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 1994;35:2734–2740.

    PubMed  CAS  Google Scholar 

  234. Vinding T. Pigmentation of the eye and hair in relation to age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol Copenh 1990;6:53–58.

    Google Scholar 

  235. Mitchell P, Smith W, Wang JJ. Iris color, skin sun sensitivity, and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 1998;105:1359–1363.

    Article  PubMed  CAS  Google Scholar 

  236. Klein R, Klein BE, Jensen SC, Cruickshanks KJ. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 1998;116:506–513.

    PubMed  CAS  Google Scholar 

  237. Wang JJ, Jakobsen K, Smith W, Mitchell P. Five-year incidence of age-related maculopathy in relation to iris, skin or hair colour, and skin sun sensitivity: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 2003;31:317–321.

    Article  PubMed  CAS  Google Scholar 

  238. Tomany SC, Klein R, Klein BE. The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2003;110:1526–1533.

    Article  PubMed  Google Scholar 

  239. Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration. An Australian case-control study. Ophthalmology 1997;104:770–776.

    PubMed  CAS  Google Scholar 

  240. Berendschot T, Willemse-Assink JJ, Bastiaanse M, de Jong PT, van Norren D. Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 2002;43:1928–1932.

    PubMed  Google Scholar 

  241. Taylor HR, Munoz B, West S, Bressler NM, Bressler SB, Rosenthal FS. Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc 1990;88:163–173.

    PubMed  CAS  Google Scholar 

  242. Cruickshanks KJ, Klein R, Klein BE. Sunlight and age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol 1993;111:514–518.

    PubMed  CAS  Google Scholar 

  243. Delcourt C, Carriere I, Ponton-Sanchez A, Fourrey S, Lacroux A, Papoz L. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liees al’ Age (POLA) study. Arch Ophthalmol 2001;119:1463–1468.

    PubMed  CAS  Google Scholar 

  244. Pham TQ, Wang JJ, Rochtchina E, Mitchell P. Pterygium/pinguecula and the five-year incidence of age-related maculopathy. Am J Ophthalmol 2005;139:536–537.

    Article  PubMed  Google Scholar 

  245. West SK, Rosenthal FS, Bressler NM, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 1989;107:875–879.

    PubMed  CAS  Google Scholar 

  246. Cruickshanks KJ, Klein R, Klein BE, Nondahl DM. Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2001; 119:246–250.

    PubMed  CAS  Google Scholar 

  247. Tomany SC, Cruickshanks KJ, Klein R, Klein BE, Knudtson MD. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2004;122:750–757.

    Article  PubMed  Google Scholar 

  248. Hirvela H, Luukinen H, Laara E, Sc L, Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 1996;103:871–877.

    PubMed  CAS  Google Scholar 

  249. Miyazaki M, Nakamura H, Kubo M, et al. Risk factors for age related maculopathy in a Japanese population: the Hisayama study. Br J Ophthalmol 2003;87:469–472.

    Article  PubMed  CAS  Google Scholar 

  250. Marin-Castano ME, Elliot SJ, Potier M, et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003;44:50–59.

    Article  PubMed  Google Scholar 

  251. Espinosa-Heidmann DG, Marin-Castano ME, Pereira-Simon S, Hernandez EP, Elliot S, Cousins SW. Gender and estrogen supplementation increases severity of experimental choroidal neovascularization. Exp Eye Res 2005;80:413–423.

    Article  PubMed  CAS  Google Scholar 

  252. Vingerling JR, Dielemans I, Witteman JC, Hofman A, Grobbee DE, de Jong PT. Macular degeneration and early menopause: a case-control study. BMJ 1995;310: 1570–1571.

    PubMed  CAS  Google Scholar 

  253. Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust New Zealand J Ophthalmol 1997;25Suppl 1:S13–S15.

    Google Scholar 

  254. Klein BE, Klein R, Jensen SC, Ritter LL. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1994;92:289–295.

    PubMed  CAS  Google Scholar 

  255. Defay R, Pinchinat S, Lumbroso S, Sutan C, Delcourt C. Sex steroids and age-related macular degeneration in older French women: the POLA study. Ann Epidemiol 2004;14:202–208.

    Article  PubMed  Google Scholar 

  256. Klein BE, Klein R, Lee KE. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the beaver dam eye study. Am J Ophthalmol 2000; 130:322–326.

    Article  PubMed  CAS  Google Scholar 

  257. Snow KK, Cote J, Yang W, Davis NJ, Seddon JM. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol 2002;134:842–848.

    Article  PubMed  CAS  Google Scholar 

  258. Abramov Y, Borik S, Yahalom C, et al. The effect of hormone therapy on the risk for agerelated maculopathy in postmenopausal women. Menopause 2004;11:62–68.

    Article  PubMed  Google Scholar 

  259. Rulon LL, Robertson JD, Lovell MA, Deibel MA, Ehmann WD, Markesber WR. Serum zinc levels and Alzheimer’ s disease. Biol Trace Elem Res 2000;75:79–85.

    Article  PubMed  CAS  Google Scholar 

  260. Klein R, Klein BE, Jensen SC, Moss SE, Cruickshanks KJ. The relation of socioeconomic factors to age-related cataract, maculopathy, and impaired vision: the Beaver Dam Eye Study. Ophthalmology 1994;101:1969–1979.

    PubMed  CAS  Google Scholar 

  261. Klein R, Klein BE, Jensen SC, Moss SE. The relation of socioeconomic factors to the incidence of early age-related maculopathy: the Beaver Dam Eye Study. Am J Ophthalmol 2001;132:128–131.

    Article  PubMed  CAS  Google Scholar 

  262. Huang GH, Klein R, Klein BE, Tomany SC. Birth cohort effect on prevalence of age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 2003;157: 721–729.

    Article  PubMed  Google Scholar 

  263. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995;142:404–409.

    PubMed  CAS  Google Scholar 

  264. Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol 1986;104:216–219.

    PubMed  CAS  Google Scholar 

  265. Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and agerelated macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 2000;118:351–358.

    PubMed  CAS  Google Scholar 

  266. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998;116:583–587.

    PubMed  CAS  Google Scholar 

  267. Delcourt C, Michel F, Colvez A, Lacroux A, Delage M, Vernet MH. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol 2001;8:237–249.

    Article  PubMed  CAS  Google Scholar 

  268. Klein R, Klein BE, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1993;100:406–414.

    PubMed  CAS  Google Scholar 

  269. Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol 2001;119:1259–1265.

    PubMed  CAS  Google Scholar 

  270. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 2003;121:785–792.

    Article  PubMed  Google Scholar 

  271. Klein R, Klein BE, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104:1804–1812.

    PubMed  CAS  Google Scholar 

  272. Klein R, Klein BEK, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2003;110:1273–1280.

    Article  PubMed  Google Scholar 

  273. van Leeuwen R, Ikram MK, Vingerling JR, Witteman JC, Hofman A, de Jong PT. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 2003;44:3771–3777.

    Article  PubMed  Google Scholar 

  274. Wang JJ, Mitchell P, Rochtchina E, Tan AG, Wong TY, Klein R. Retinal vessel wall signs and the 5-year incidence of age related maculopathy: the Blue Mountains Eye Study. Br J Ophthalmol 2004;88:104–109.

    Article  PubMed  CAS  Google Scholar 

  275. van Leeuwen R, Klaver CC, Vingerling JR, et al. Cholesterol and age-related macular degeneration: is there a link? Am J Ophthalmol 2004;137:750–752.

    PubMed  Google Scholar 

  276. Voutilainen-Kaunisto RM, Terasvirta ME, Uusitupa MI, Niskanen LK. Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance. Diabetes Care 2000; 23:1672–1678.

    Article  PubMed  CAS  Google Scholar 

  277. Clemons TE, Kurinij N, Sperduto RD. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 2004;122:716–726.

    Article  PubMed  CAS  Google Scholar 

  278. Wu KH, Wang JJ, Rochtchina E, Foran S, Ng MK, Mitchell P. Angiotensin-converting enzyme inhibitors (ACEIs) and age-related maculopathy (ARM): cross-sectional findings from the Blue Mountains Eye Study. Acta Ophthalmol Scand 2004;82:298–303.

    Article  PubMed  CAS  Google Scholar 

  279. Christen WG, Glynn RJ, Ajani UA, et al. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol 2001;119:1143–1149.

    PubMed  CAS  Google Scholar 

  280. Penfold PL, Provis JM, Billson FA. Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefes Arch Clin Exp Ophthalmol 1987;225:70–76.

    Article  PubMed  CAS  Google Scholar 

  281. Espinosa-Heidmann DG, Suner IJ, Hernandez EP, Monroy D, Csaky KG, Cousins SW. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003;44:3586–3592.

    Article  PubMed  Google Scholar 

  282. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115–126.

    Article  PubMed  CAS  Google Scholar 

  283. Margolis TP, Lietman T, Strauss E. Infectious agents and ARMD: a connection? Am J Ophthalmol 2004;138:468–470.

    Article  PubMed  Google Scholar 

  284. Klein R, Klein BE, Tomany SC, Cruickshanks J. Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy. Arch Ophthalmol 2003;121:674–678.

    Article  PubMed  Google Scholar 

  285. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004;291:704–710.

    Article  PubMed  CAS  Google Scholar 

  286. Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI, Mansour S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol 2003;121:478–482.

    Article  PubMed  Google Scholar 

  287. Miller DM, Espinosa-Heidmann DG, Legra J, et al. The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am J Ophthalmol 2004;138:323–328.

    Article  PubMed  Google Scholar 

  288. Cousins SW, Espinosa-Heidmann DG, Csaky KG. Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol 2004;122:1013–1018.

    Article  PubMed  Google Scholar 

  289. Ishida O, Oku H, Ikeda T, Nishimura M, Kawagoe K, Nakamura K. Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration? Br J Ophthalmol 2003;87:523–524.

    Article  PubMed  CAS  Google Scholar 

  290. Wang JJ, Mitchell P, Smith W, Gillies M, Billson F. Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2003;10:37–48.

    Article  PubMed  Google Scholar 

  291. Klein R, Klein BE, Moss SE. Diabetes, hyperglycemia, and age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1992;99:1527–1534.

    PubMed  CAS  Google Scholar 

  292. Mitchell P, Wang JJ. Diabetes, fasting blood glucose and age-related maculopathy: The Blue Mountains Eye Study. Aust New Zealand J Ophthalmol 1999;27:197–199.

    Article  CAS  Google Scholar 

  293. Sperduto RD, Hiller R, Seigel D. Lens opacities and senile maculopathy. Arch Ophthalmol 1981;99:1004–1008.

    PubMed  CAS  Google Scholar 

  294. Liu IY, White L, LaCroix AZ. The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health 1989;79:765–769.

    PubMed  CAS  Google Scholar 

  295. Klein R, Klein BE, Wang Q, Moss SE. Is age-related maculopathy associated with cataracts? Arch Ophthalmol 1994;112:191–196.

    PubMed  CAS  Google Scholar 

  296. Wang JJ, Mitchell PG, Cumming RG, Lim R. Cataract and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol 1999;6:317–326.

    Article  PubMed  CAS  Google Scholar 

  297. Oliver M. Posterior pole changes after cataract extraction in elderly subjects. Am J Ophthalmol 1966;62:1145–1148.

    PubMed  CAS  Google Scholar 

  298. Blair CJ, Ferguson J, Jr. Exacerbation of senile macular degeneration following cataract extraction. Am J Ophthalmol 1979;87:77–83.

    PubMed  CAS  Google Scholar 

  299. Klein BE, Klein R, Moss SE. Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1999;22:1984–1987.

    Article  PubMed  CAS  Google Scholar 

  300. van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, Pameyer JH, de Jong PT. Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol 1994;78:441–445.

    Article  PubMed  Google Scholar 

  301. Pollack A, Marcovich A, Bukelman A, Oliver M. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology 1996;103:1546–1554.

    PubMed  CAS  Google Scholar 

  302. Pollack A, Marcovich A, Bukelman A, Zalish M, Oliver M. Development of exudative age-related macular degeneration after cataract surgery. Eye 1997;11:523–530.

    PubMed  Google Scholar 

  303. Armbrecht AM, Findlay C, Aspinall PA, Hill AR, Dhillon B. Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J Cataract Refract Surg 2003;29:686–693.

    Article  PubMed  Google Scholar 

  304. Klein R, Klein BE, Wong TY, Tomany SC, Cruickshanks KJ. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Arch Ophthalmol 2002;120:1551–1558.

    PubMed  Google Scholar 

  305. Klein BE, Klein R, Moss SE. Incident cataract surgery: the Beaver Dam Eye Study. Ophthalmology 1997;104:573–580.

    PubMed  CAS  Google Scholar 

  306. Wang JJ, Klein R, Smith W, Klein BEK, Tomany S, Mitchell P. Cataract surgery and the 5-year incidence of age-related macular degeneration: Pooled findings from the Beaver Dam and Blue Mountains Eye Studies. Ophthalmology 2003;110:1960–1967.

    Article  PubMed  Google Scholar 

  307. Tan AG, Wang JJ, Rochtchina E, Jakobsen K, Mitchell P. Increase in cataract surgery prevalence from 1992–1994 to 1997–2000: analysis of two population cross-sections. Clin Experiment Ophthalmol 2004;32:284–288.

    Article  PubMed  Google Scholar 

  308. Boker T, Fang T, Steinmetz R. Refractive error and choroidal perfusion characteristics in patients with choroidal neovascularization and age-related macular degeneration. Ger J Ophthalmol 1993;2:10–13.

    PubMed  CAS  Google Scholar 

  309. Maltzman BA, Mulvihill MN, Greenbaum A. Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol 1979;11:1197–1201.

    PubMed  CAS  Google Scholar 

  310. Sandberg MA, Tolentino MJ, Miller S, Berson EL, Gaudio AR. Hyperopia and neovascularization in age-related macular degeneration. Ophthalmology 1993;100:1009–1013.

    PubMed  CAS  Google Scholar 

  311. Wang JJ, Mitchell P, Smith W. Refractive error and age-related maculopathy: the Blue Mountains Eye Study. Invest. Ophthalmol Vis Sci 1998;39:2167–2171.

    CAS  Google Scholar 

  312. Ikram MK, van Leeuwen R, Vingerling JR, Hofman A, de Jong PT. Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 2003;44:3778–3782.

    Article  PubMed  Google Scholar 

  313. Wong TY, Klein R, Klein BE, Tomany SC. Refractive errors and 10-year incidence of age-related maculopathy. Invest Ophthalmol Vis Sci 2002;43:2869–2873.

    PubMed  Google Scholar 

  314. Wang JJ, Jakobsen KB, Smith W, Mitchell P. Refractive status and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 2004;32:255–258.

    Article  PubMed  Google Scholar 

  315. Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol 1999;128:45–53.

    Article  PubMed  CAS  Google Scholar 

  316. Foran S, Wang JJ, Mitchell P. Causes of incident visual impairment: the blue mountains eye study. Arch Ophthalmol 2002;120:613–619.

    PubMed  Google Scholar 

  317. Chia EM, Wang JJ, Rochtchina E, Smith W, Cumming RG, Mitchell P. Impact of Bilateral Visual Impairment on Health-Related Quality of Life: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 2004;45:71–76.

    Article  PubMed  Google Scholar 

  318. Maguire M. Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2004;111:1307–1316.

    Article  PubMed  Google Scholar 

  319. La Forge RG, Spector WD, Sternberg J. The relationship of vision and hearing impairment to one-year mortality and functional decline. J Aging Health 1992;4:126–148.

    Article  Google Scholar 

  320. Rudberg MA, Furner SE, Dunn JE, Cassel CK. The relationship of visual and hearing impairments to disability: an analysis using the longitudinal study of aging. J Gerontol 1993;48:M261–M265.

    PubMed  CAS  Google Scholar 

  321. Carabellese C, Appollonio I, Rozzini R, et al. Sensory impairment and quality of life in a community elderly population. J Am Geriatr Soc 1993;41:401–407.

    PubMed  CAS  Google Scholar 

  322. Salive ME, Guralnik J, Glynn RJ, Christen W, Wallace RB, Ostfeld AM. Association of visual impairment with mobility and physical function. J Am Geriatr Soc 1994;42: 287–292.

    PubMed  CAS  Google Scholar 

  323. Rubin GS, Roche KB, Prasada Rao P, Fried LP. Visual impairment and disability in older adults. Optom Vis Sci 1994;71:750–760.

    Article  PubMed  CAS  Google Scholar 

  324. Dargent Molina P, Hays M, Breart G. Sensory impairments and physical disability in aged women living at home. Int J Epidemiol 1996;25:621–629.

    Article  Google Scholar 

  325. Lee PP, Spritzer K, Hays RD. The impact of blurred vision on functioning and well-being. Ophthalmology 1997;104:390–396.

    PubMed  CAS  Google Scholar 

  326. Lee P, Smith JP, Kington R. The relationship of self-rated vision and hearing to functional status and well-being among seniors 70 years and older. Am J Ophthalmol 1999;127: 447–452.

    Article  PubMed  CAS  Google Scholar 

  327. Reuben DB, Mui S, Damesyn M, Moore AA, Greendale GA. The prognostic value of sensory impairment in older persons. J Am Geriatr Soc 1999;47:930–935.

    PubMed  CAS  Google Scholar 

  328. Harries U, Landes R, Popay J. Visual disability among older people: a case study in assessing needs and examining services. J Public Health Med 1994;16:211–218.

    PubMed  CAS  Google Scholar 

  329. Ivers RQ, Cumming RG, Mitchell P, Attebo K. Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc 1998;46:58–64.

    PubMed  CAS  Google Scholar 

  330. Ivers R, Cumming R, Mitchell P. Poor vision and risk of falls and fractures in older Australians: the Blue Mountains Eye Study. NSW Public Health Bull 2002;13:8–10.

    Article  Google Scholar 

  331. Ivers RQ, Norton R, Cumming RG, Butler M, Campbell AJ. Visual impairment and risk of hip fracture. Am J Epidemiol 2000;152:633–639.

    Article  PubMed  CAS  Google Scholar 

  332. Ivers RQ, Optom B, Cumming RG, Mitchell P, Simpson JM, Peduto AJ. Visual risk factors for hip fracture in older people. J Am Geriatr Soc 2003;51:356–363.

    Article  PubMed  Google Scholar 

  333. Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 2001;108: 1893–1900.

    Article  PubMed  CAS  Google Scholar 

  334. Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol 2002;120:1041–1044.

    PubMed  Google Scholar 

  335. Casten RJ, Rovner BW, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol 2004;15:181–183.

    Article  PubMed  Google Scholar 

  336. Klein R, Cruickshanks KJ, Klein BE, Nondahl DM, Wiley T. Is age-related maculopathy related to hearing loss? Arch Ophthalmol 1998;116:360–365.

    PubMed  CAS  Google Scholar 

  337. Klaver CC, Ott A, Hofman A, Assink JJ, Breteler MM, de Jong PT. Is age-related maculopathy associated with Alzheimer’ s disease? The Rotterdam Study. Am J Epidemiol. 1999;150:963–968.

    PubMed  CAS  Google Scholar 

  338. Wong TY, Klein R, Nieto FJ, et al. Is early age-related maculopathy related to cognitive function? The Atherosclerosis Risk in Communities Study. Am J Ophthalmol 2002;134:828–835.

    Article  PubMed  Google Scholar 

  339. Wang JJ, Mitchell P, Smith W. Vision and low self-rated health: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 2000;41:49–54.

    PubMed  CAS  Google Scholar 

  340. Wang JJ, Mitchell P, Cumming RG, Smith W. Visual impairment and nursing home placement in older Australians: the Blue Mountains Eye Study. Ophthal Epidemiol 2002;10: 3–13.

    Article  Google Scholar 

  341. Kleiner RC, Enger C, Alexander MF, Fine SL. Contrast sensitivity in age-related macular degeneration. Arch Ophthalmol 1988;106:55–57.

    PubMed  CAS  Google Scholar 

  342. Klein R, Klein BE, Moss SE. Age-related eye disease and survival: the Beaver Dam Eye Study. Arch Ophthalmol 1995;113:333–339.

    PubMed  CAS  Google Scholar 

  343. Wang JJ, Mitchell P, Simpson JM, Cumming RG, Smith W. Visual impairment, age-related cataract, and mortality. Arch Ophthalmol 2001;119:1186–1190.

    PubMed  CAS  Google Scholar 

  344. Taylor HR, McCarty CA, Nanjan MB. Vision impairment predicts five-year mortality. Trans Am Ophthalmol Soc 2000;98:91–96.

    PubMed  CAS  Google Scholar 

  345. Buch H, Vinding T, la Cour M, Jensen GB, Prause JU, Nielsen NV. Age-related maculopathy: a risk indicator for poorer survival in women: the Copenhagen City Eye Study. Ophthalmology 2005;112:305–312.

    Article  PubMed  Google Scholar 

  346. Owen CG, Fletcher AE, Donoghue M, Rudnicka AR. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom? Br J Ophthalmol 2003;87:312–317.

    Article  PubMed  CAS  Google Scholar 

  347. Hopley C, Carter R, Mitchell P. Measurement of the economic impact of visual impairment from age-related macular degeneration in Australia. Clin Experiment Ophthalmol 2003;31:522–529.

    Article  PubMed  Google Scholar 

  348. Lanchoney DM, Maguire MG, Fine SL. A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration. Comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients. Arch Ophthalmol 1998;116:1045–1052.

    PubMed  CAS  Google Scholar 

  349. Hopley C, Salkeld G, Wang JJ, Mitchell P. Cost utility of screening and treatment for early age-related macular dageneration with zinc and antioxidants. Br J Ophthalmol 2004;88:450–454.

    Article  PubMed  CAS  Google Scholar 

  350. Wright AF. Strategies for mapping susceptibility genes in age-related maculopathy. Eye 2001;15:401–406.

    PubMed  CAS  Google Scholar 

  351. Thakkinstian A, Bowe S, McEvoy M, Smith W, Attia J. Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and metaanalysis. Am J Epidemiol 2006 (in press).

    Google Scholar 

  352. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005;102:7227–7232.

    Article  PubMed  CAS  Google Scholar 

  353. Jakobsdottir J, Conely YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005;77: 389–407.

    Article  PubMed  CAS  Google Scholar 

  354. Rivera A, Fisher SA, Fritsche LG et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005;14:3227–3236.

    Article  PubMed  CAS  Google Scholar 

  355. Schmidt S, Hauser MA, Scott WK et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006;78:852–864.

    Article  PubMed  CAS  Google Scholar 

  356. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006;38: 458–462.

    Article  PubMed  CAS  Google Scholar 

  357. Haan MN, Klein R, Klein BE, et al. Hormone therapy and age-related macular degeneration: the Women’s Health Initiative Sight Exam Study. Arch Ophthalmol 2006;124:988–992.

    Article  PubMed  Google Scholar 

  358. Klein R, Klein BE, Knudrson MD, Wong TY, Shankar A, Tsai MY. Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy. Am J Ophthalmol 2005;140:35–44.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Vision Research, Department of Ophthalmology, Westmead Millennium Institute, University of Sydney, Westmead Hospital, Westmead, N.S.W., Australia

    Jie Jin Wang MMed, PhD & Paul Mitchell MD, PhD

  2. Ophthalmology and Visual Science, University of Wisconsin-Madison, Madison, WI

    Ronald Klein MD, MPh

Authors
  1. Jie Jin Wang MMed, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Mitchell MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ronald Klein MD, MPh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT

    Joyce Tombran-Tink PhD  & Colin J. Barnstable DPhil  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Wang, J.J., Mitchell, P., Klein, R. (2007). Epidemiology of Age-Related Macular Degeneration Early in the 21st Century. In: Tombran-Tink, J., Barnstable, C.J. (eds) Retinal Degenerations. Ophthalmology Research. Humana Press. https://doi.org/10.1007/978-1-59745-186-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-186-4_2

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-620-7

  • Online ISBN: 978-1-59745-186-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation